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ABSTRACT 
Hypoxia is an imbalance in oxygen delivery and oxygen consumption, ultimately 
affecting cell survival. Low levels of oxygen diminish adenosine triphosphate synthesis resulting 
from a decline in oxidative phosphorylation in the mitochondria, therefore inducing apoptosis 
and cell death. To create a hypoxia mimicked environment, we used hypoxia mimetic 
compounds cobalt and nickel to treat human neuroblastoma (NMB) cells. Using hypoxic mimic 
human neuronal cell models, we examined and compared the effects of compound-induced 
hypoxia on NMB cell proliferation. The cells were treated with 100µM and 300µM 
concentrations of each compound at 24- and 48-hour intervals. To investigate cell proliferation, 
the thymidine analog EdU was used, which incorporates into DNA during DNA synthesis. Flow 
Cytometry was used to measure and analyze the fluorescence of EdU incorporation. Results 
showed the inhibition of cell proliferation using both nickel and cobalt treated cells as compared 
to the control cells with no treatment. Furthermore, the inhibition of cell proliferation was 
dependent upon the exposure time and concentration dose. Interestingly under the same 
concentration, cobalt produced greater inhibition of cell proliferation than nickel. Although the 
causes of differences are unclear currently, possible reasons are discussed and hypothesized. In 
conclusion, this study demonstrated differences in the inhibition of cell proliferation using nickel 
or cobalt hypoxic mimetic compounds in human neuronal cells. Further research to determine 
mechanisms behind different cell models will provide additional information and understanding 
in regard to hypoxia related diseases.  
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INTRODUCTION 
Oxygen is essential for all eukaryotic survival and is a key element for the production of 
adenosine triphosphate (ATP). ATP is the main energy source for biological functions, such as 
homeostasis, self-repair and tissue sustenance (Guzy & Schumacker, 2006). To meet the supply-
demand of ATP, oxidative phosphorylation utilizes metabolic substrates NADH and NADH2 to 
synthesize ATP from ADP and inorganic phosphates. In mitochondria, oxidative 
phosphorylation requires oxygen consumption to synthesize ATP. There are several intricate 
pathways that allow cells to sense oxygen level fluctuations leading to the development of 
adaptations that maintain oxygen tension. When cells encounter insufficient ATP production 
with the loss of oxygen, the survival of the cell is threatened. This disadvantage leads to cells 
evolving different responses to preserve the required oxygen for survival. Different tissues have 
adapted various defense mechanisms under low oxygen conditions known as hypoxia. For 
example, arterial chemoreceptors can monitor blood oxygen levels, or cells that secrete 
hormones to regulate adequate supply of tissue oxygenation (Guzy & Schumacker, 2006). Upon 
hypoxia, some cells have the ability to decrease oxygen utilization, allowing for an increase in 
survival rate.  
Hypoxia is the condition of low levels of oxygen and is around 3-5% O2 within the 
cellular environment (Humar et al., 2002). Pathologically, hypoxia occurs during acute and 
chronic vascular disease, pulmonary disease, and cancer, ultimately leading to cell death if 
severe and/or prolonged. Further, different tissues require specific amounts of oxygen, when 
altered these changes are critical in the pathogenesis of diseases such as stroke, myocardial 
infarction and chronic lung disease (Lopez-Barneo et al., 2001). Hypoxia threatens cell survival 
because it is a precursor to anoxia; a cellular environment that contains zero oxygen. The 
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physiological responses to hypoxia can be categorized as acute or chronic. Chronic hypoxia 
responses can take hours, days or even weeks, whereas acute response times are seconds to 
minutes. Examples of acute responses are hyperventilation (arterial and airway chemoreceptors), 
activation of glucose uptake (cardiac and skeletal muscle, fat tissue), or increase heart output 
(peripheral chemoreceptors, heart muscle). Chronic responses occur at the cellular and/or gene 
level, such as activation of glucose metabolism and transport, erythropoiesis (bone marrow), 
angiogenesis and neovascularization (vascular endothelium, hypoxic or ischemic tissues), 
production of vasodilators (vascular endothelium and smooth muscle), and the changes of 
various gene expression (Semenza, 2000). Acute responses depend upon excitable cells that have 
oxygen sensitive ion channels, allowing for quick responses. Prolonged hypoxia leads to the 
changes in gene expression for transporters, enzymes and growth factors that aid against oxygen 
deficiency (Humar et al, 2002). Key regulators of transcriptional responses to oxygen deprivation 
are proteins known as hypoxia-inducible factors, which sense instabilities in oxygen levels. To 
maintain oxygen homeostasis, developmental and physiological pathways are triggered to 
upregulate oxygen delivery (Huang et al., 2014).  
Ultimately, hypoxia will lead to non-oxidative synthesis of ATP, neovascularization, and 
an increase in oxygen carrying capacity of blood. Cellular response to hypoxia leads to the 
upregulation of various genes that aid in glucose uptake, glucose metabolism, apoptosis, 
glycolysis, glycolytic enzymes, and vascular endothelial growth factor (VEGF) (Humar et al., 
2002; Guzy & Schumacker, 2006; Diguilio et al., 2018). Cellular response is not immediate 
because upregulation of genes can include transcription and translation, which requires hours or 
days.  
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HIF TRANSCRIPTION FACTORS AND ISOFORMS 
Hypoxia-inducible factors (HIF) belong to a family of transcription factors, including 
HIF-1, HIF-2, and HIF-3, which can regulate several hypoxia response genes. While differential 
regulation of the HIF isoforms isn’t completely understood, they all depend upon the 
hydroxylation of proline and asparaginyl residues conserved in the N and C termini (Ratcliffe, et 
al., 2017). Of the isoforms, HIF-1 and HIF-2 are the most well studied. HIF-1 and HIF-2 have 
similar DNA-binding and heterodimerization domains but different sequences in their 
transactivating domains, suggesting that they have unique target genes. Studies have suggested 
that HIF-1a induces the expression of several glycolytic genes, while HIF-2 is cell-specific and 
tissue limited (Hu et al., 2003; Raval et al., 2005; Wigpur et al., 2016). Mole and colleagues 
compared HIF-1a and HIF-2a DNA binding discovering many loci bound both HIF-a isoforms, 
however, substantially more bound to HIF-1a than HIF-2a. Additionally, further analyses found 
distinct patterns of binding occurred for HIF-1a (Mole et al., 2009). 
In addition to the transcriptional regulation, the a-subunits of HIF-1 and HIF-2 are 
differentially regulated at the transcriptional, translation, and post-translation modification levels. 
Although there are overlaps of binding sites between HIF-1 and HIF-2, studies conducted by 
Mole et al. showed HIF-2 did not offer transcriptional changes during hypoxic responses but 
translational changes in MCF-7 cells. HIF-2 creates a hypoxia-regulated translation initiation 
complex between RNA binding protein RBM4 and cap-binding protein eIF4E2. This complex 
recruits a wide variety of mRNAs to promote active translation at different polysomes (Wigerup 
et al., 2016).  
Furthermore, Wigpur and collaborators utilized experimental and clinical data to show 
HIFs regulated metastasis and treatment resistance in various tumors. Leading to the hypothesis 
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that HIF inhibitor are likely to target important oncogenic processes or pathways. Interestingly, 
the two isoforms tend to have contrasting effects on tumor growth, specifically in cell cycle and 
apoptotic regulators c-MYC and p53. In summary, HIF-2 and HIF-1 can have opposite effects, 
such is the case in essential cell cycle regulator and oncogene, c-Myc. HIF-1a inhibits c-Myc 
ultimately suppressing proliferation and leads to c-Myc degradation. Contritely, HIF-2a 
enhances c-Myc activity and leads to cell cycle progression in renal carcinoma cells, NIH3T3 
cells, HEK293 cells, and embryonic ECs (Wigerup et al., 2016; Gordan et al., 2007). Additional 
studies by Holmquist-Mengelbier et al. exhibited HIF-1a under chronic hypoxia degrades over 
time, while HIF-2a accumulates continuously in select neuroblastoma cells. This implicated that 
HIF-1a mediates quick responses while HIF-2a mediates late responses for hypoxia (Holmquist-
Mengelbier et al., 2006). 
Both HIFs are co-expressed in cancers. HIF-1a is primarily active initially under acute 
hypoxia, while HIF-2a dominates later under chronic hypoxia, as well as normoxic conditions 
(Holmquist-Mengelbier et al., 2006). The most notable difference among the two are tissue 
specific differences with few similarities as tumor suppressor proteins in glioblastoma and 
teratoma models. Hypoxia inducible factors-1 and 2 overexpression have been associated with 
poor clinical outcomes in patients with various cancers. In addition, the HIF-1a protein is 
overexpressed in various common solid malignant tumors including breast, colon, gastric, lung, 
skin, ovarian, pancreatic, prostate, and renal carcinomas compared to their respective normal 
tissues. While the two isoforms have poor prognosis’ when upregulated in cancer, the cancer 
type varied. HIF-1a overexpression led to poor survival in cervical cancer, endometrial 
carcinoma, oligodendroglioma, ovarian cancer, and different breast cancer subtypes. HIF-2a 
overexpression led to poor prognosis in breast cancer, glioblastoma, head and neck squamous 
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carcinoma, and non-small cell lung cancer. Conversely, HIF-1a overexpression showed an 
improvement of diagnoses in head and neck cancer, and non-small cell lung cancer (Wigerup et 
al., 2016). 
Of the HIF isoforms, HIF-1 is well studied. The structure of HIF-1 is a basic helix-loop-
helix(bHLH)/PAS heterodimeric transcription factor, containing the dimerization of two 
subunits, 120-kDa HIF-1a and 91-94kDa HIF-1b (Chanel et al., 1998; Brunelle et al., 2005). 
This specific hypoxia-inducible transcription factor is ubiquitously expressed and is an important 
factor during hypoxia cellular responses. Of the two subunits, HIF-1a is oxygen-regulated and 
required for cellular response to hypoxia. The b subunit is unique to HIF-1, also referred as the 
aryl hydrocarbon receptor nuclear translocator or ARNT, is constitutively expressed and has the 
ability to dimerize with the arylhydrocarbon receptor (Semenza, 2000). Notably, HIF is regulated 
through enzymatic post-translational hydroxylation of the a subunit.  
Hypoxia-inducible factor-1a is constitutively transcribed, and translated, but readily 
degraded under normoxic conditions. This protein has 826 amino acids with bHLH and PAS 
domains located on the N-terminal, which are critical for both dimerization and DNA binding 
(Lopez-Barneo et al., 2001). There are two transactivation domains and one protein stability 
region located on the C-terminal of HIF-1a. The domain fundamental for stabilization is located 
between residues 401 and 603.  
After stabilization, HIF-1a translocates to the nucleus, where it dimerizes with HIF-1b. 
The transcription factor will bind to the A/GCGTG consensus motif in the promoter regions of 
target genes known as hypoxia response elements (HREs) (Wigerup et al., 2016; Urrutia and 
Aragones, 2018). When the monomers form the heterodimeric transcription factor, the genes 
transcribed will favor tumor aggression, as well as the cell’s survival under hypoxia (Diguilio et 
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al., 2018). For HIF-1a stabilization, the a-subunit activates through the detection of low oxygen 
levels (around 5% O2), which is sensed within 30 mins. HIF-1a accumulation begins to steadily 
increase until it reaches full accumulation near 0.5% O2 roughly 4-8 hours later (Lopez-Barneo 
et al., 2001; Jiang et al., 1996; Brunelle et al., 2005). 
With the decrease in oxygen tension, HIF-1 binds to HREs on the 3’ flanking region of 
the erythropoietin gene, the 5’ flanking region of the VEGF gene and the regulatory elements 
encoding glycolytic enzymes (Chanel et al., 1998).  There is a HIF-binding region on all the 
genes that are hypoxia-sensitive. Hypoxia potentiates HIF-1 activity through HIF-1a 
transcriptional activation, mRNA stabilization, nuclear translocation, and the prevention of HIF-
1a degradation (Semenza, 2000). There are cis-acting DNA sequences that are required and a 
trans-acting factor that allows binding to HIF-1 (Wang et al, 1995). 
 There are multiple factors required for degradation of HIF-1a, including proteins, 
enzymes, oxygen, and other cofactors. Prolyl hydroxylases (PHDs) are a family of enzymes with 
oxidative properties. PHD’s are tetramers containing 2 hydroxylase units and 2 protein disulfide 
isomerase subunits that covalently modify HIF-1a (Harris, 2002). The family includes PHD1, 
PHD2, and PHD3. PHDs hydroxylate specific proline residues (Pro402 and Pro564) within the 
oxygen-dependent degradation (ODD) domain and facilitate interactions with ubiquitin ligase 
(Brunelle et al., 2005). These enzymes require 2-oxoglutarate (a-ketoglutarate), oxygen as 
substrates and iron as a cofactor (Guzy & Schumacker, 2006; Urrutia and Aragones, 2018).  
Therefore, PHDs sense deviations in the required substrates and cofactors. With a decline in 
oxygen tension, PHD ability to hydroxylate is limited due to the restricted oxygen available.  
The a subunit’s ability to sense a decline in oxygen tension is due to its ODD domain. 
Located within the ODD domain are highly conserved proline residues which are required for 
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degradation via the PHD/pVHL pathway. This pathway includes the ubiquitination and 
degradation of HIF-1a by prolyl hydroxylases and ubiquitin ligase. PHDs are essential for post-
translational modification signals to properly degrade HIF-1a. Proline hydroxylation modifies 
the a subunit required for the von Hippel Lindau (pVHL) tumor suppressor protein to bind to the 
modified unit. This protein, also known as the E3 recognition component of the ubiquitin ligase, 
is required for ubiquitin labeling and the proteasomal degradation of HIF-1a.  
There are stimuli that regulate HIFs such as growth factors, cytokines, hormones, and 
other various stressors. Many growth factors have cognate receptors that interact and signal the 
phosphoinositide 3-kinase (PI3K) or Ras/MAPK pathways which express HIF. Further, PI3K 
pathway inhibition will lead to basal and mitogen-induced HIF inhibition (Wigerup et al., 2016). 
Although these non-hypoxia driven stimuli can normalize hypoxic environments, there are 
elements that induce hypoxia.   
HYPOXIA MIMETICS 
 Chemical compounds that can stabilize HIF-1a under normoxic conditions are known as 
hypoxia mimetics. These compounds artificially induce hypoxia by stabilizing HIF-1a and/or 
inhibiting PHD enzymes both directly and indirectly.  Further, directly targeting PHDs can lead 
to inhibition of activity altogether. Many mimetics will indirectly target PHDs by depleting the 
availability of iron, increasing oxygen species production, or creating competition.  There are 
several compounds commonly used as hypoxia mimetics, such as Cobalt and Nickel.  
 Cobalt (II) Chloride hexahydrate (CoCl2) is a water-soluble chemical mediator of 
hypoxia, also known as, a hypoxic mimetic (Diguilio et al., 2018). Cobalt treatment can increase 
the cellular content of HIF-1a through the direct inhibition of prolyl hydroxylases, as well as, 
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increasing ROS generation (Chandel et al., 1998). Therefore, cobalt induces gene expression, 
specifically RNAs encoding glycolytic enzymes to combat against hypoxia.  
 Water-soluble and water-insoluble nickel differ in carcinogen potency as well as entrance 
into the cell. As a hypoxic mimetic NiCl2 blocks iron uptake, while simultaneously competing 
against iron dependent enzymes leading to iron depletion, as well as, HIF-1a stabilization (Costa 
et al., 2005). Prolyl hydroxylases are indirectly inhibited due to their dependence upon iron as a 
co-factor. This inhibition allows HIF-1a to stabilize, and activate the hypoxia signaling cascade. 
HYPOXIA AND CANCER 
A tumor microenvironment includes blood and lymphatic vessels, fibroblasts, immune 
cells, and an extracellular matrix. Upon progression, cancer cells have limited access to oxygen 
and nutrients, causing hypoxic regions. These regions allow for aberrant vascularization which is 
related to cancer progression. Cancer cells will undergo genetic and adaptive changes to promote 
survival and proliferation under oxidative stress. These adaptions stimulate malignant 
phenotypes promoting aggressive tumor behavior. Continual proliferation will lead tumors to 
outgrow blood supply, resulting in chronic hypoxia. 
Peter Vaupel and colleagues utilized oxygen electrodes to study tumor oxygen supply for 
squamous tumors of head and neck, cervical and breast cancers.  The results of the study show 
low oxygen tension in tumors led to an increase in metastasis, decreasing patient survival in all 
cancers studied.  There are reports about VHL mutations and HIF-2a upregulation inducing a 
hypoxic environment in renal cancer, and cerebellar hemangioblastomas (Harris, 2002). 
Additionally, the overexpression of HIF-1a was reported in colon, breast, gastric, lung, skin, 
ovarian, pancreatic, prostate and renal carcinomas (Zhong, H. et al, 1999).   
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PURPOSE OF EXPERIMENT 
Based on the information above, this study examined and compared the effects of 
hypoxic mimetic compounds, cobalt and nickel, on NMB cell proliferation using a human 
neuroblastoma NMB cell model. The proliferation rates of surviving cells under challenges of 
the hypoxic mimic compound at various exposure time and concentrations were investigated. A 
hypoxia induced cell model was created using cobalt, nickel, and human neuroblastoma cells. To 
measure the cell proliferation, cells were treated with EdU then examined and analyzed with a 
flow cytometer.  
FLOW CYTOMETRY 
The MASQUANT analyzer is a highly sensitive multi-parameter flow cytometer that 
utilizes fluidic and optical components for cell analysis. The machine allows for the rapid 
analysis of multiple characteristics of different cells supplying both qualitative and quantitative 
data. Possible characteristics that can be measured include cell size, cytoplasmic complexity, 
DNA or RNA content, and a range of membrane-bound and intracellular proteins (Brown and 
Wittwer, 2000).  
Forward scatter (FSC) measures physical properties such as size, while side scatter (SSC) 
measures the granularity of the cell. Flow cytometry utilizes fluorescent dyes to bind and 
intercalate with cellular components, including DNA or RNA. Additionally, antibodies can be 
employed to promote the binding of specific proteins and fluorescent dyes.  
Flow cytometry utilizes lasers to excite the fluorescent molecules to higher energy states. 
When the molecules come down to their resting state, the fluorochromes will emit light energy at 
a higher or different wavelength. Using multiple fluorochromes will allow the simultaneous 
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measurement of several different cell properties due to the different emission wavelengths. In 
this study, fluorescent 488 is the dye used to measure EdU incorporation. 
Within the machine, cells are sheathed in an isotonic fluid to create a single cell line or 
laminar flow, thus allowing each individual cell to pass through the light emission. Each cell will 
pass through a beam of monochromatic light that intersects the cell. The beams then bounce off 
in different directions depending on the properties of each cell. Optics collect the lights emitted 
into various filters and dichroic mirrors which allow specific wavelengths to be isolated from the 
rest (Brown and Wittwer, 2000). These signals can then be detected by photomultiplier tubes 
allowing for digitization for computer analysis, via MASQUANT analyzer.  
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MATERIALS AND METHODS 
CELL CULTURE 
Human Neuroblastoma Cells (NMB) were cultured in Roswell Park Memorial Institute (RPMI) 
(Invitrogen, Carlsbad, CA, USA), supplemented with 10% Fetal Bovine Serum (FBS) (Atlanta 
Biologicals, Flowery Branch, GA, USA) and treated with antibiotics penicillin and gentamicin. 
The NMBs were grown in culture flasks at 37°C in 5% CO2 incubator.  
TREATMENT 
Cells were seeded into six well plates at 7x105 cells concentration per well. Cells were incubated 
overnight, harvested and then treated with 100µM and 300µM NiCl2 and CoCl2 concentrations, 
separately. Cells were incubated for 24- and 48-hour exposure times. Additionally, each well was 
treated with 1µM EdU for 16 hours to track proliferation.  
CELL PROLIFERATION ASSAY 
The neuroblastoma cells were harvested using PBS EDTA, then centrifuged at 1000 RPMs for 
five minutes. Cells resuspended in 1% BSA in PBS then centrifuged and fixed using the click-it 
fixative, 4% paraformaldehyde. The NMB cells were centrifuged and resuspended in 1% BSA in 
PBS to quench any unreacted fixative. Cells were permeabilized using click-it permeabilization 
wash and reagent. EdU buffer additive was added to permeabilized NMB cells to allow for the 
detection of EdU under dye fluorescent 488. The fluorescent signals of control and treated cells 
were examined using Flow cytometry. Parameters used were: FSC 207V, SSC 322V and B1 
316V. 
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CLICK- IT REACTION 
To detect cell proliferation, cells were incubated with 5-ethynyl-2’-deoxyuridine (EdU) which is 
a nucleoside analog of thymidine. EdU directly measures active DNA synthesis of the cell cycle. 
It is cell permeable and is incorporated into the DNA during Synthesis (S) phase. Further, EdU is 
an easier, faster option that doesn’t require a denaturation step. Click-it chemistry was used to 
detect the presence of EdU by a copper-catalyzed covalent reaction between a fluorescent azide 
and the alkyne on the EdU molecule. This reaction forms a stable triazole ring, allowing Flow 
cytometry to detect and measure the fluorescence of EdU. The fluorescent dyes are required for 
measurement because the dyes will intercalate into the helical structure of DNA. This 
fluorescence is then directionally proportional to the amount of DNA in the nucleus. Utilizing 
this fluorescence to amount for any increase or decrease in DNA, this can show cell proliferation 
(increase in DNA) or the inhibition of proliferation (decrease in DNA). Flow results were 
analyzed using MASQUANT Analysis and depicted via histograms.  
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RESULTS 
 Cells developing adaptive and/or genetic changes to survive under a low oxygen 
environment can lead to tumorigenesis. Therefore, hypoxia is an important element for cancer 
research. These adaptations promote malignant phenotypes, ultimately leading to aggressive 
tumor behavior (Harris, 2002). Many advanced cancers, such as fibroblasts, neck tumors, 
cervical cancer, and soft tissue sarcoma, are known to induce the overexpression of HIF-1a 
which is associated with vascularity, and tumor aggression, thus combating hypoxia and 
encouraging cell survival (Wigerup et al., 2016).  
 Nickel and Cobalt are two commonly used hypoxic mimetics. Therefore, we utilized 
these compounds to induce a hypoxic environment, then examined and compared how the metals 
affected the cell proliferation of surviving neuroblastoma cells under various exposure times and 
doses. Cells were then incubated with the thymidine analog EdU which is incorporated into the 
DNA during DNA synthesis. Incorporation of EdU was measured and analyzed using flow 
cytometry and MASQUANT.  
Human NMB neuronal cells were treated with concentrations of 100µM and 300µM of 
CoCl2 and NiCl2 to create a hypoxic mimic neuronal cell model. All cells were treated with 1µM 
of EdU for 16 hours. Control cells were treated with only EdU. Prior to this study, we conducted 
experiments with three different concentrations of EdU at 24- and 48-hour intervals, to find a 
concentration without producing cytotoxicity. Of the three concentrations, 1µM EdU yielded the 
results we required with minimal cell death.  
 The graphs are measuring EdU incorporation which occurs during S Phase. The higher 
the FITC signal indicates more nucleotide incorporation, suggesting cell proliferation. The large 
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second peak is the fluorescence of EdU assimilation into the cells, after DNA synthesis. The first 
and smaller peak is indicative of G1 phase. S phase is the dip between the peaks, which is the 
area EdU begins incorporation into the DNA. If there is a decrease in EdU incorporation, then 
there will be a shift to the left or a decrease in the second peak.   
DETERMINATION OF EDU INCORPORATION OF NICKEL TREATMENT 
The results of EdU incorporation of cells treated with Nickel for 24 hours are shown in 
Figures 1a-c. At 24 hours, Nickel treated cells showed slight inhibition of cell proliferation from 
the graph’s shift to the left, best depicted in Figure 2 the overlay of graphs from Figures 1a-c. 
Figure 1 shows a slight variation from the control peaks (1a), but there isn’t a significant 
difference. Even between the variance in concentrations there isn’t a substantial disparity. For 
better understanding, the overlay of Figure 2 shows a clear shift to the left and a dip at 1e1. This 
confirms more cells have stayed in G1 phase and have not proceeded through S phase verifying a 
decrease in cell proliferation.  
Conversely, the higher exposure time shows a significant effect on cellular proliferation. 
Figures 3a-c represent EdU incorporation of cells treated with Nickel for 48 hours. There is clear 
inhibition of proliferation at the longer exposure time and at the higher concentration seen in 
Figure 3c. There is a noteworthy increase in the first peak, and a clear shift to the left. These 
distinctions indicate a decrease in cellular proliferation based on EdU incorporation. Again, the 
control (3a) shows the second peak is the fluorescence of EdU incorporation. Inhibition is better 
depicted in Figure 4, the overlay of graphs from Figures 3a-c. This overlay further confirms the 
significance of an exposure time of 48 hours and 300µM concentration. There is a slight shift to 
the left at the 24-hour exposure, however, cellular proliferation is clearly stalled at the longer 
exposure time. Any shifts to the left or increase in the first peak verify the lack of EdU 
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incorporation. No integration means cells are not undergoing synthesis, due to proliferation 
inhibition.  
DETERMINATION OF EDU INCORPORATION OF COBALT TREATMENT 
The results of the cobalt treatments revealed a greater effect on cell proliferation than 
nickel. At 24-hour exposure, the cells treated with cobalt shifted immensely as seen in Figures 
5a-c. The histograms of Figure 5a and Figure 5b show cells treated with cobalt shifted to the left, 
as well as, the first peak increases in size. This clear shift represents cell proliferation inhibition 
because EdU is not being incorporated due to cells not transitioning through S phase. Further, 
Figure 5c characterizes the stark contrast at the higher concentration of cobalt exposure. Figure 6 
illustrates the overlay of the histograms in Figure 5, demonstrating the inhibition in cell 
proliferation. The 300µM cobalt treatment is completely void of cells within the second peak. 
The lack of the second peak shows that the cells did not transition past S phase, therefore no EdU 
was incorporated during synthesis. Although the cells were treated with the same concentration 
and exposure times, Cobalt yielded significant results compared to Nickel. Inhibition of cell 
proliferation occurred quicker, even at the lower dosages.   
 The most significant inhibition of proliferation is in Figures 7a-c. These graphs depict 
EdU incorporation of cells treated with Cobalt for 48 hours. The histogram of Figure 7c are cells 
treated with 300µM of Cobalt for 48 hours, which show a single peak demonstrating that cell 
proliferation was indeed inhibited. The treated cells did not transition into S phase but were 
completely fixed in G1. Figure 7b yielded a larger difference than the same concentration at a 
shorter exposure time (Figure 5b). Further observation of full inhibition is portrayed in the 
overlay of Figures 7a-c as shown in Figure 8; all cells shifted to the left and are only in the first 
peak confirming no EdU incorporation. For both hypoxic mimetics, the results showed that cell 
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inhibition is time and concentration dependent. The longer the exposure time the greater the 
inhibition, and correspondingly for a higher concentration of each compound. Of the two metals, 
cobalt inhibited proliferation quicker and at a smaller dose, further, the highest inhibition was 
seen at the longest exposure time along with the highest dosage.  
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Figure 1: 24-hour Nickel Treatment Results  
Figure 1a represents the control with no nickel treatment. All controls were treated with only 
1µM of EdU for 16 hours. The next two graphs are both 24-hour treatments of NiCl2. Figure 1b 
shows the results of cells treated with 100µM NiCl2 and 1µM of EdU. Figure 1c depicts the 
results of cells treated with 300µM NiCl2 and 1µM EdU. 
 
 
 
 
 
 
 
 
 
 
Image citation notice: all images included in this thesis are generated by author unless otherwise cited. 
a. b. c. 
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Figure 2: Overlay of 24-hour Nickel Treatments 
The control is represented by black. Pink is the 24-hour 100µM Nickel treatment and blue is the 
24-hour 300µM Nickel treatment, all were treated with 1µM EdU for 16 hours. The shift to the 
left is indicative of proliferation inhibition due to more cells stuck in the G1 phase (peak one) as 
opposed to transitioning through S phase. There is a decrease in the second peak, as further 
verification of the decrease in proliferation.  
 
 26 
 
 
Figure 3: Results for 48-hour Nickel treatment 
Figure 3a is the control, which was only treated with 1µM EdU for 16 hours. Figure 3b is the 
results of cells treated at 48 hours with 100µM NiCl2 and 1µM EdU 16-hour treatment. Figure 3c 
is the results of the cells treated at 48-hour with 300µM Nickel and 1µM EdU 16-hour treatment, 
which shows a clear increase in the first peak. Comparing Figures 3a and 3b,, there is a shift to 
the left, as well as an increase in the first peak, which is indicative of a decrease in cellular 
proliferation due to cells being stuck in G1 phase. The most significance is seen in 3c. The first 
peak has a large increase, as well as a shift to the left. This shows proliferation inhibition because 
EdU is not getting incorporated into the cells because they are not passing through S phase. 
 
 
a. b. c. 
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Figure 4: Overlay of 48-hour Nickel treatment  
Black represents the control which was treated with 1µM EdU for 16 hours. Orange signifies the 
cells treated with 100µM Nickel and 1µM EdU at a 48-hour and 16-hour exposure times, 
respectively. Green denotes the cells treated with 300µM Nickel and 1µM EdU at a 48- and 16-
hour intervals, respectively. At 100µM Nickel there is a clear shift to the left, showing more cells 
are in the first peak. However, at 300µM Nickel there is a large shift to the left and a large 
increase in the first peak because cells are stuck in the G1 phase and the EdU is not being 
detected.  
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Figure 5: Results of 24-hour Cobalt Treatments 
Figure 5a represents the control treated with 1µM EdU for 16 hours. Figure 5b is the 24-hour 
100µM Cobalt treatment with 16 hours of 1µM EdU. Lastly, Figure 5c is a 24-hour 300µM 
Cobalt treatment with 16 hours of 1µM EdU. The first peak in the 5b shows an increase 
compared to the control. While, 5c shows a clear shift to the left and changes in both peaks. Both 
are indicative of cell proliferation inhibition because the EdU fluorescence is not being detected, 
meaning the cells are not transitioning into S phase.  
 
a. b. c. 
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Figure 6: Overlay of 24-hour Cobalt Treatments 
Black represents our control; the red indicates the 24-hour 100µM Cobalt with 16-hour 1µM 
EdU treatment and the purple is the 24-hour 300µM Cobalt with 16-hour 1µM EdU treatment. 
Looking at the overlay, there is a clear shift to the left in both concentrations. The 300µM cobalt 
treatment shows a greater effect on the neuroblastoma cells than the 100µM and Nickel 
treatments. The black line shows where EdU is incorporated, while the purple line shows a 
complete lack of the second peak, indicating no cells in that area. This confirms that EdU was 
not incorporated into the DNA because the cells never passed through the S phase. 
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Figure 7: Results of 48-hour Cobalt Treatments  
Figure 7a is the control treated with 1µM EdU for 16 hours. Figure 7b represents the results of 
cells treated with 48-hour 100µM cobalt and 16-hour 1µM EdU. Figure 7c depicts the results of 
cells treated with 48-hour 300µM cobalt and 16-hour 1µM EdU. The 48-hour 300µM cobalt 
treatment only has one peak due to cells being fixed in G1 phase. This peak shows that cell 
proliferation was fully inhibited due to a lack of cells transitioning.  
 
a. b. c. 
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Figure 8: Overlay of 48-hour Cobalt Treatment 
The control is signified by black, and blue indicates cells treated at 48 hours with 100µM cobalt 
and 16-hour 1µM EdU. Green characterizes the cells treated at 48 hours with 300µM cobalt and 
1µM EdU. There is a clear shift to the left for both treated cells. Green shifted more than all 
other treatments, showing that 300µM of cobalt yielded the greatest effect on cell proliferation of 
neuroblastoma cells. At this exposure time, all cells were prevented from entering S phase.  
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DISCUSSION 
Hypoxia has no conclusive definition, except that it is a condition where oxygen levels 
are below the requirement for cell survival. Scientists and doctors cannot agree on definitive 
percentages to claim a tissue or cell is hypoxic due to the varying oxygen levels in diverse tissues 
(Hockel and Vaupel, 2001). Conversely, scientists agree understanding the effects of hypoxia on 
cells and the human body is important because of the possibilities to discover benefits to help 
treat other diseases, such as cancer. Normally, hypoxia leads to a decrease in ATP levels, an 
increase in oxygen related stress and ultimately, cell death. In this study, human neuroblastoma 
(NMB) cells were treated with hypoxic mimetic compounds CoCl2 and NiCl2 to create a hypoxic 
mimetic cell model system. Results showed that nickel and cobalt-induced hypoxic mimic 
condition can cause cell death which corroborates the cobalt results from “Human 
Neuroblastoma Adaptation to Cobalt Chloride-Induced Hypoxia” (McAuliffe., 2017). However, 
there were still surviving cells under these hypoxic mimic conditions. Likely they have 
developed the adaptive responses. As compared to the non-treated control cells, these surviving 
cells showed a significant decrease in EdU incorporation as the concentrations and exposure time 
increased. Although the compounds are similar, the results were significantly incongruent. In 
fact, the results from nickel treated cells were not as substantial as the cobalt treatments. Both 
mimetics induced a hypoxic environment through the stabilization and accumulation of HIF-1a, 
resulting in inhibition of cell proliferation. 
In this study, cobalt chloride and nickel chloride were used to induce a hypoxic 
environment. Nickel showed slight inhibition of proliferation at all concentrations and exposure, 
however, the longest exposure with the highest dose yielded the most significance. In fact, the 
24-hour treatments at both concentrations showed trivial variability. Though there was a slight 
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shift between Figures 1b and 1c the difference isn’t as significant as the longer exposure time. 
The shift can be better analyzed in the overlay shown in Figure 2. Moreover, the 48-hour 100µM 
exposure did not show a substantial disparity as displayed in Figures 3a and 3b. The 48-hour 
300µM treatment in Figure 3c exhibited significant inhibition with a sizeable increase in the first 
peak and a large shift to the left. The overlay of Figure 4 are the graphs from Figures 3a-c, and a 
shift for the 100µM treatment can be seen, while the treatment with 300µM shows a decrease in 
the second peak and an increase in the first peak. These changes denote inhibition of cell 
proliferation at the 48-hour exposure for both 100µM and 300µM nickel treatments because EdU 
was not incorporated as seen in the nonexistent second peak. Conversely, cobalt significantly 
inhibited cell proliferation at 24-hour 100µM treatment, and amplified inhibition as exposure and 
concentration increased. 
Cobalt yielded greater influence on cell proliferation than nickel, even at the lowest dose 
and least exposure time. At the shortest exposure, cobalt inhibited proliferation more than nickel 
at the highest concentration and longest exposure time. The 24-hour 100µM treatment showed a 
shift and an increase in the first peak, similar to nickel exposure, as presented in Figure 5b, 
compared to the control in Figure 5a. However, the 24-hour 300µM treatment yielded a complete 
change, with nearly all the cells shifting out of the second peak as displayed in Figure 5c. The 
large variations can be fully analyzed in the overlay of Figure 6, where the complete shift of 
Figure 5c confirms inhibition of cell proliferation. As the exposure and concentration increased, 
inhibition of proliferation grew greater as well. The 48-hour 100µM treatment shows a severe 
increase in the first peak and a large shift to the left. The 100µM concentration at both 24-hour 
(Figure 5b) and 48-hour (Figure 7b) yielded increases in the first peak and shifts, however, the 
longer exposure produced greater effects. Comparably, the 300µM generated the largest 
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inhibition at both exposure times, with highest inhibition at 48-hour as seen in Figure 7c. The 
control shows the second peak is 1e2 to 1e3 on the x-axis, this signifies EdU incorporation. 
Utilizing this information to further analyze Figure 7c, there is no peak between 1e2 and 1e3, due 
to the lack of EdU incorporation. All cells are stuck in G1 phase, concluding full inhibition of 
cell proliferation. To fully analyze the effects of cobalt at 48-hour exposure, the overlay in 
Figure 8 illuminates the complete shift for 300µM and the large increase of cells stuck in G1 for 
100µM.   
Cells could not incorporate EdU due to inhibition, preventing the transition into/out of 
synthesis phase. Possible explanations could be the mechanism behind hypoxia induction, the 
amount of ROS produced or cobalt toxicity. Littman et al. conducted a study to examine 
chondrogenesis and compare cobalt induced hypoxia with a cellular environment living in low 
oxygen levels in human mesenchymal stem cells treated for 24 hours, 4 days and 7 days. From 
their results, cobalt treated cells resulted in cell death more than cells treated within a hypoxic 
environment. They theorized cobalt may induce apoptosis pathways, resulting in higher levels of 
cell death. Comparing these results to the results in this study, cobalt may inhibit cell 
proliferation more than Nickel because it induces pathways leading to cell death. Further 
hypothesis includes the different mechanism of prolyl hydroxylase inhibition. Cobalt directly 
inhibits PHDs, while nickel indirectly inhibits PHDs through blocking iron uptake, and 
competing against iron dependent enzymes (Chandel et al., 1998; Costa et al., 2005). Comparing 
and examining the difference between direct and indirect inhibition may further aid in 
understanding key differences of cobalt and nickel as hypoxic mimetics.    
Both metals belong to group VII in the periodic chart, confirming similar chemical 
properties. Further, each compound produces reactive oxygen species and allows for the 
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accumulation of HIF-1a. Long term exposure to NiCl2 as well as CoCl2 has shown detrimental 
effects on the human body (Yao et al., 2014). Extensive exposure to NiCl2 will lead to an 
accumulation of nickel intracellularly. In a study conducted by Costa et al., at 24 hours of 
exposure nickel ions reside in the cytoplasm, however, when increased to 72 hours, the ions 
translocate to the nucleus. In the same study, Cobalt is proven to have harsh consequences on 
embryonic stem cells. Nickel compounds are water-insoluble and water-soluble. The water-
insoluble nickel are readily phagocytized while the water-soluble diffuses through the cell 
membrane (NTP Toxicology and Carcinogenesis Studies of Ni Sulfate Hexahydrate, 1996). 
Combining the results from previous studies, we hypothesized that the translocation of nickel 
will increase the harmful effects on the cell, including cell proliferation. This hypothesis was 
proven correct when we saw inhibition of proliferation due to prolonged NiCl2 exposure.  
Due to the severity and possible detrimental effects, cells have adapted defense 
mechanisms to fight hypoxia and alleviate oxygen tension. As described by Hockel and Vaupel, 
pathological causes of hypoxia include low oxygen partial pressure/oxygen tension in arterial 
blood due to pulmonary diseases or high altitudes (hypoxemic hypoxia), reduced ability of blood 
to carry oxygen, reduced tissue perfusion, deterioration of the diffusion of geometry and inability 
of cells to use oxygen due to intoxication caused from poisoning. While the underlying 
mechanism behind sensing oxygen change is not wholly understood, a family of proteins known 
as hypoxia inducible factors has an oxygen sensitive subunit to mediate hypoxia. Most notably, 
HIF-1a is oxygen sensitive, however, it is also important for tumor microenvironment (Diguilio 
et al., 2018).  
Hypoxia-regulated pathways that overlap with oncogenic signaling pathways include 
cellular proliferation, angiogenesis, metabolism, apoptosis, immortalization, and migration 
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(Harris, 2002). Further, cellular proliferation induces growth factors that promote cellular 
proliferation, migration, and regeneration, as well as, transforms growth factor-b and platelet-
derived growth factor glioblastoma. Hypoxia induced angiogenesis via growth factors, such as 
VEGF, can be blocked by inhibitors of oncogene signaling pathways. The tumor 
microenvironment includes blood vessels, lymphatic vessels, fibroblasts, immune cells and 
chemicophysical components which leads to restricted oxygen and nutrients. This limited access 
leads to hypoxic regions which allows for aberrant vascularization which is considered a feature 
of cancer and promotes cancer progression. Further, hypoxia induces differentiation of non-
specific CD4+ T cells into regulatory T cells or T helpers (Petrova et al., 2018). Additionally, 
Gatenby and colleagues used oxygen electrodes to study tumor oxygen supply; their results 
showed low oxygen tension in tumors lead to an increase in metastasis and poor survival in 
patients for squamous tumors of head and neck, cervical and breast cancer. 
Under hypoxia, cells switch from glucose metabolism and oxygen-dependent 
tricarboxylic acid to glycolysis, the oxygen-independent metabolic pathway. Kim et al. provided 
the first evidence that HIF-1 actively participates in metabolic reprogramming from the TCA 
cycle to glycolysis by showing that HIF-1 directly targets the gene encoding pyruvate 
dehydrogenase kinase 1 (PDK1). This led to the inactivation of pyruvate dehydrogenase (PDH), 
which catalyzes pyruvate into acetyl-CoA. Cancer cells can utilize glycolysis as its primary 
mechanism of ATP production. The utilization of glycolysis instead of the TCA cycle permits 
cancer cells to consume less energy. Further, studies show that telomerase increases when cancer 
cells are within a hypoxic environment, which leads to cellular immortalization (Harris, 2002). 
 From the analysis of our results, we conclude that the inhibition of cell proliferation is 
dose-dependent and time-dependent. Paralleling the compounds, we conclude cobalt has a 
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greater effect on cell proliferation than nickel. For future studies, we can further compare other 
hypoxic mimetic compounds, such as desferrioxamine (DFO), and its effects on cell 
proliferation. More experimental analysis can lead to a better understanding of the mechanisms 
behind cobalt and nickel induced hypoxia, as well as, future possibilities of utilizing these 
understandings to treat cancer.  
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